Novel therapeutic options for Dravet and Lennox-Gastaut syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel therapeutic options for Dravet and Lennox-Gastaut syndrome

Published:2021-01-11 Issue:11 Volume:21 Page:1191-1194
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Verrotti Alberto¹,Striano Pasquale²³^ORCID

Affiliation:

1. Department of Pediatrics, University of Perugia, Perugia, Italy

2. Pediatric Neurology and Muscular Diseases Unit, IRRCS Istituto Giannina Gaslini, Genova, Italy

3. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova, Genova, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2020.1862651

Reference30 articles.

1. Emerging drugs for the treatment of Dravet syndrome

2. The pharmacological management of Lennox-Gastaut syndrome and critical literature review

3. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

4. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

5. Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol: metabolism and clinical efficacy in epileptic patients;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

2. Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding;Neuropsychiatric Disease and Treatment;2023-09

3. An Italian consensus on the management of Lennox-Gastaut syndrome;Seizure;2022-10

4. Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine;Frontiers in Pharmacology;2022-05-20

5. Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies;Expert Review of Neurotherapeutics;2021-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3